Immune reconstitution for the treatment of myasthenia gravis - the case for cladribine

Authors
Category Primary study
Conference16th International Symposium Molecular Basis of Pathology and Therapy in Neurological Disorders
Year 2024
This article has no abstract
Epistemonikos ID: a2b3da4638ce95b8ba811664283f3ac2fae22779
First added on: Apr 12, 2025